This multicenter work from Japanrandomized 3200 patients to receive biodegradable polymer biolimus eluting stent(Nobori) or everolimus-eluting stent with permanent polymer (Xience / Promus). The primary end point for efficacy was any revascularizationlesion. A two year follow up the Nobori stent was non-inferior to death or myocardial infarction (7.83% versus 7.69%) and TLR (6.23% versus 5.95%).
Conclusion
The evolution in terms of safety and efficacy of DES with biodegradable polymer biolimus is equivalent to that of everolimus-eluting stents with permanent polymer.
7_masahiro_natsuaki_slides
Masahiro Natsuaki
2014-03-31
Original title: Two-year Outcome of a Randomized Trial Comparing Second Generation Drug-eluting Stents Using Either Biodegradable Polymer or Durable Polymer: the NOBORI Biolimus-Eluting versus XIENCE/PROMUS Everolimus-eluting Stent Trial (NEXT).
